← The SEC Ephemeris: the whole map
LEO Pharma A/S tralokinumab
In the graph: all 1 documents (3 pages).
- Application
- BLA 761180
- Ticker
- LEO Pharma A/S
- Product
- tralokinumab
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- April 23, 2021
From FDA letters and SEC filings. Not investment or medical advice.